In Treatment of Type 2 diabetes mellitus Vogli Rapid M 0.5 Tablet is a medicine that helps to control high blood glucose (sugar) levels. It helps get rid of extra glucose from your body through urine. It also slows down the breaking down of food in our intestine to simple glucose (sugar), thereby decreasing the rise in blood glucose levels after meals. Lowering blood glucose levels is an essential part of managing diabetes. If you can control the level, you will reduce the risk of getting any of the serious complications of diabetes such as kidney damage, eye damage, nerve problems and loss of limbs. Vogli Rapid M 0.5 Tablet will reduce the risk of dying from cardiovascular disease if you have type 2 diabetes and already have cardiovascular disease. Taking this medicine regularly along with proper diet and exercise will help you live a normal, healthy life. You should keep using it for as long as it is prescribed because it is protecting your future health.
It is unsafe to consume alcohol with Vogli Rapid M 0.5 Tablet.
Information regarding the use of Vogli Rapid M 0.5 Tablet during pregnancy is not available. Please consult your doctor.
Information regarding the use of Vogli Rapid M 0.5 Tablet during breastfeeding is not available. Please consult your doctor.
It is not known whether Vogli Rapid M 0.5 Tablet alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Vogli Rapid M 0.5 Tablet should be used with caution in patients with kidney disease. Dose adjustment of Vogli Rapid M 0.5 Tablet may be needed. Please consult your doctor.
Vogli Rapid M 0.5 Tablet should be used with caution in patients with liver disease. Dose adjustment of Vogli Rapid M 0.5 Tablet may be needed. Please consult your doctor.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
| QTY | Stock Status | Brand Name | Generic Name | Strength | Form | Size | MRP | Discount | Net Cost | MFR | Type | Add Cart |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Vogli-Rapid M 0.3mg/0.5mg/500mg Tablet SR | Voglibose (0.3mg) + Repaglinide (0.5mg) + Metformin (500mg) | 0.3mg / 0.5mg / 500mg | Tablet SR | strip of 10 tablet sr | ₹110.00 | ₹110.00 | ₹0.00 | Medl... | RX |